(Millions of yen)
As of March 31, 2022 | As of March 31, 2023 | |
---|---|---|
Assets | ||
Current assets | ||
Cash and deposits | 511,502 | 595,961 |
Notes and accounts receivable - trade, and contract assets |
119,829 | 184,633 |
Finance receivables | 222,463 | 226,042 |
Merchandise and finished goods | 192,292 | 259,848 |
Work in process | 43,293 | 24,835 |
Raw materials and supplies | 64,006 | 66,901 |
Short-term loans receivable | 624 | 1,022 |
Other | 111,367 | 121,481 |
Allowance for doubtful accounts | (9,459) | (5,766) |
Total current assets | 1,255,920 | 1,474,959 |
Non-current assets | ||
Property, plant and equipment | ||
Buildings and structures, net | 85,110 | 86,288 |
Machinery, equipment and vehicles, net | 132,116 | 134,524 |
Tools, furniture and fixtures, net | 64,638 | 56,044 |
Land | 123,068 | 116,734 |
Construction in progress | 24,521 | 61,011 |
Total property, plant and equipment | 429,455 | 454,603 |
Intangible assets | 38,273 | 40,003 |
Investments and other assets | ||
Investment securities | 98,433 | 95,361 |
Long-term loans receivable | 2,817 | 2,760 |
Retirement benefit asset | 4,775 | 4,045 |
Deferred tax assets | 43,669 | 74,029 |
Other | 58,818 | 59,660 |
Allowance for doubtful accounts | (3,720) | (3,898) |
Total investments and other assets | 204,794 | 231,959 |
Total non-current assets | 672,523 | 726,565 |
Total assets | 1,928,443 | 2,201,524 |
Liabilities | ||
Current liabilities | ||
Notes and accounts payable - trade | 324,091 | 369,495 |
Electronically recorded obligations - operating | 56,612 | 92,009 |
Short-term borrowings | 21,778 | 31,330 |
Commercial papers | 43,000 | 47,500 |
Current portion of long-term borrowings | 292,134 | 73,098 |
Lease liabilities | 3,751 | 3,519 |
Accounts payable - other and accrued expenses |
204,894 | 233,874 |
Income taxes payable | 8,487 | 13,510 |
Provision for product warranties | 50,029 | 54,605 |
Provision for contingent loss | - | 10,504 |
Other | 79,393 | 77,939 |
Total current liabilities | 1,084,173 | 1,007,389 |
Non-current liabilities | ||
Long-term borrowings | 95,768 | 248,048 |
Lease liabilities | 24,101 | 24,785 |
Deferred tax liabilities | 17,127 | 320 |
Retirement benefit liability | 32,240 | 36,688 |
Other | 44,731 | 53,915 |
Total non-current liabilities | 213,968 | 363,758 |
Total liabilities | 1,298,142 | 1,371,148 |
Net assets | ||
Shareholders' equity | ||
Share capital | 284,382 | 284,382 |
Capital surplus | 199,837 | 199,620 |
Retained earnings | 169,694 | 338,424 |
Treasury shares | (1,382) | (989) |
Total shareholders' equity | 652,531 | 821,438 |
Accumulated other comprehensive income | ||
Valuation difference on available-for-sale securities |
1,111 | 977 |
Deferred gains or losses on hedges | (31) | (35) |
Foreign currency translation adjustment | (32,571) | (5,438) |
Remeasurements of defined benefit plans | (14,267) | (15,802) |
Total accumulated other comprehensive income |
(45,759) | (20,298) |
Share acquisition rights | 195 | 29 |
Non-controlling interests | 23,334 | 29,208 |
Total net assets | 630,301 | 830,376 |
Total liabilities and net assets | 1,928,443 | 2,201,524 |
(Millions of yen)
For the fiscal year ended March 31, 2022 |
For the fiscal year ended March 31, 2023 |
|
---|---|---|
Net sales | 2,038,909 | 2,458,141 |
Cost of sales | 1,676,459 | 1,935,341 |
Gross profit | 362,450 | 522,799 |
Selling, general and administrative expenses | ||
Advertising and promotion expenses | 39,147 | 51,535 |
Freight costs | 49,849 | 72,747 |
Provision of allowance for doubtful accounts | 1,834 | (605) |
Remuneration, salaries and allowances for directors (and other officers) |
66,875 | 74,711 |
Retirement benefit expenses | 3,781 | 3,982 |
Depreciation | 12,715 | 14,516 |
Research and development expenses | 57,507 | 61,025 |
Other | 43,405 | 54,390 |
Total selling, general and administrative expenses | 275,118 | 332,304 |
Operating profit (loss) | 87,331 | 190,495 |
Non-operating income | ||
Interest income | 1,942 | 7,623 |
Dividend income | 567 | 677 |
Foreign exchange gains | 9,241 | 5,421 |
Share of profit of entities accounted for using equity method |
8,527 | - |
Other | 4,183 | 2,603 |
Total non-operating income | 24,462 | 16,326 |
Non-operating expenses | ||
Interest expenses | 5,085 | 3,559 |
Litigation expenses | 1,586 | 4,306 |
Share of loss of entities accounted for using equity method |
- | 12,209 |
Financing expenses | 1,476 | 706 |
Other | 2,675 | 4,017 |
Total non-operating expenses | 10,824 | 24,799 |
Ordinary profit (loss) | 100,969 | 182,022 |
Extraordinary income | ||
Gain on sales of non-current assets | 2,858 | 27,271 |
Gain on sales of investment securities | 99 | 24 |
Gain on sales of investments in capital of subsidiaries and associates |
2,791 | - |
Gain on reversal of asset retirement obligations | 833 | 268 |
Other | 548 | 129 |
Total extraordinary income | 7,131 | 27,693 |
Extraordinary losses | ||
Loss on retirement of non-current assets | 2,887 | 1,941 |
Loss on sales of non-current assets | 23 | 1,713 |
Impairment losses | 1,451 | 5,015 |
Loss related to Russian operations | 8,220 | 19,928 |
Loss related to Chinese operations | - | 10,504 |
Other | 827 | 2,483 |
Total extraordinary losses | 13,411 | 41,586 |
Profit (loss) before income taxes | 94,689 | 168,129 |
Income taxes - current | 13,362 | 36,410 |
Income taxes - deferred | 2,177 | (44,642) |
Total income taxes | 15,539 | (8,232) |
Profit (loss) | 79,149 | 176,361 |
Profit (loss) attributable to non-controlling interests |
5,112 | 7,630 |
Profit (loss) attributable to owners of parent | 74,037 | 168,730 |
(Millions of yen)
For the fiscal year ended March 31, 2022 |
For the fiscal year ended March 31, 2023 |
|
---|---|---|
Cash flows from operating activities | ||
Profit (loss) before income taxes | 94,689 | 168,129 |
Depreciation | 53,630 | 60,132 |
Impairment loss | 1,451 | 5,015 |
Loss related to Russian operations | 8,220 | 19,928 |
Loss related to Chinese operations | - | 10,504 |
Increase (decrease) in allowance for doubtful accounts |
955 | (3,632) |
Increase (decrease) in retirement benefit liability |
2,349 | 8,003 |
Interest and dividend income | (2,510) | (8,300) |
Interest expenses | 5,085 | 3,559 |
Foreign exchange losses (gains) | (6,160) | (5,354) |
Share of loss (profit) of entities accounted for using equity method |
(8,527) | 12,209 |
Gain on sales of investments in capital of subsidiaries and associates |
(2,791) | - |
Loss (gain) on sales and retirement of non-current assets |
53 | (23,616) |
Decrease (increase) in trade receivables | 37,935 | (59,282) |
Decrease (increase) in finance receivables | 24,744 | (3,496) |
Decrease (increase) in inventories | (13,104) | (38,739) |
Increase (decrease) in trade payables | (42,322) | 63,702 |
Increase (decrease) in accounts payable - other, and accrued expenses |
(43,290) | 6,639 |
Other, net | 12,321 | (19,341) |
Subtotal | 122,732 | 196,058 |
Interest and dividends received | 3,196 | 13,447 |
Interest paid | (5,090) | (3,620) |
Income taxes paid | (2,723) | (32,309) |
Net cash provided by (used in) operating activities |
118,114 | 173,576 |
Cash flows from investing activities | ||
Decrease (increase) in time deposits | 11,071 | (2) |
Purchase of property, plant and equipment | (76,541) | (71,041) |
Proceeds from sales of property, plant and equipment |
4,816 | 36,389 |
Purchase of intangible assets | (10,650) | (8,601) |
Other, net | 2,181 | (9,889) |
Net cash provided by (used in) investing activities | (69,123) | (53,145) |
Cash flows from financing activities | ||
Increase (decrease) in short-term borrowings | 4,201 | 8,797 |
Increase (decrease) in commercial papers | 10,500 | 4,500 |
Proceeds from long-term borrowings | 45,780 | 238,541 |
Repayments of long-term borrowings | (65,772) | (306,549) |
Dividends paid | (21) | (16) |
Dividends paid to non-controlling interests | (1,436) | (2,633) |
Other, net | (3,485) | (4,504) |
Net cash provided by (used in) financing activities | (10,234) | (61,865) |
Effect of exchange rate change on cash and cash equivalents |
28,098 | 25,890 |
Net increase (decrease) in cash and cash equivalents | 66,854 | 84,456 |
Cash and cash equivalents at beginning of period | 444,619 | 511,473 |
Cash and cash equivalents at end of period | 511,473 | 595,930 |